
    
      High risk surgical patients for PONV, scheduled for laparoscopic surgery will be distributed
      in two groups: Group I will receive aprepitant 80 mg per os and Group II will receive placebo
      per os, one hour before surgery. In the operating room, patients will be submitted to
      combined intravenous general anesthesia plus spinal anesthesia. All patients will receive
      dexamethasone 4 mg and ondansetron 4 mg intravenously during the surgical procedure. After
      surgery, patients will be monitored for pain, nausea and vomiting during 24 hours.
    
  